Brecon hires head of customer services

Company: PCI Pharma Services

Garth Simpson takes the role

Brecon Pharmaceuticals has taken the next step in the development of its customer service department with the appointment of Garth Simpson as head of customer services. He will lead the Hay-on-Wye-based firm’s team of clinical and commercial project managers.

Simpson joins Brecon with nearly seven years’ experience as a senior account manager and project manager in pharmaceutical outsourcing.

Prior to joining the industry, he worked for two years studying fuel cell technology, and spent 14 years in the chemical sector, looking at surface coating and adhesives.

You may also like

Manufacturing

At BIO Show in Boston, PCI Pharma Services to provide updates on new manufacturing facility

For leading CDMO, qualification activities for plant’s state-of-the-art sterile fill-finish and lyophilisation line are underway, with GMP production commencing summer 2025
Manufacturing

Targeted protein degraders: transforming oral therapeutics

Targeted protein degraders (TPDs) are redefining modern drug discovery and development, offering a revolutionary approach to treating diseases that were once considered to be untreatable
Manufacturing

PCI Pharma Services acquires Ajinomoto Althea, makes ground on US and European expansion

PCI's acquisition of US-based sterile fill-finish CDMO Ajinomoto Althea is part of the company's overarching strategy to expand its drug delivery services within the US and Europe
Manufacturing

PCI Pharma Serives acquires US-based sterile fill-finish CDMO, Ajinomoto Althea

This acquisition will add antibody-drug conjugate (ADC) manufacturing and US-based sterile fill-finish production capabilities to PCI's portfolio
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The rise of targeted modalities in pharmaceutical development

Targeted modalities represent a significant evolution in drug development, reports Anshul Gupte, Vice President of Pharmaceutical Development at PCI Pharma Services. They distinguish themselves from traditional small molecules and biologics by focusing on precise mechanisms of action
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

CDMO insights: development and manufacture of a highly potent OSD product

In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t the case
Manufacturing

PCI Pharma Services invests $365m into its advanced injectable packaging capabilities

The company has expanded its final assembly and packaging capabilities for advanced injectable solutions in both Europe and the US
Subscribe now